Market Overview

EU Pharmaceutical Regulations & Strategy Seminar (London, United Kingdom - October 30th-31st, 2018)

Share:

EU Pharmaceutical Regulations & Strategy Seminar (London, United Kingdom - October 30th-31st, 2018)

PR Newswire

DUBLIN, July 19, 2018 /PRNewswire/ --

The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This course will provide an up-to-date overview of the European pharmaceutical regulatory environment, procedures and obligations.

It will be of particular value as an introductory or refresher course for those involved in regulatory affairs or who interact with regulatory personnel to understand action time-lines and requests for information.

Benefits of Attending

- Understand the Legal Basis of the EU Regulatory Environment

- Discuss Development Strategy and Pre-Submission Activities

- Review Procedures for Applying for a EU Marketing Authorisation

- Discuss Post Authorisation Strategic Considerations and Obligations


Why you should attend

You will learn about the legal basis of regulation, development strategies and the strategic importance of pre-submission actions, the format for presentation of data, how the registration procedures work and post authorisation strategies and obligations.

It will be of value for regulatory affairs personnel and also for those who interact with regulatory personnel in order to understand action time-lines and information requirements.

Who Should Attend:

This course is for you, particularly if involved in:

- Regulatory affairs
- Project management
- Business planning
- Commercial Managers
- Manufacturing and QA
- Labelling and artwork
- Medical information
- Clinical
- Pharmacovigilance

Agenda:

Programme Day One

EU Regulatory Environment: Legal basis

- Key Regulations, Directives and Guidelines and information sources

Impact of Brexit

Development Strategy and Pre-Submission Activities

- Scientific advice
- Paediatric use

Case study 1: Submission Requirements

The Common Technical Document (CTD)

- Structure and content of the CTD requirements for sponsor oversight

Applying for a Marketing Authorisation in the EU

- Fast-track, conditional approval and exceptional circumstances
- Adaptive licensing
- Centralised procedure (CP)
- Decentralised procedure (DCP)
- Mutual Recognition procedure (MRP)
- National procedures

Case Study 2: Registration strategy: discussion; will Brexit alter this?

Managing Product labelling

- Company core data sheets
- Updates to Summary of Product Characteristics

Programme Day Two

Abridged Applications

- Legal basis
- Data exclusivity
- Generics-definition and criteria

Post Authorisation Obligations and Strategic Considerations

- Line extension
- Classification switch
- Parallel trade (Impact of Brexit)

Obligations

- Pharmacovigilance
- Variations
- Renewals

Safety Reporting

- Pharmacovigilance

License variations

- Type I and Type II variations
- Procedures and timelines
- Case study 3: Post Authorisation Strategy: discussion; will Brexit alter this?

License Renewals

Requirements and procedures

- Periodic safety update reports
- The Sunset Clause
For more information about this conference visit https://www.researchandmarkets.com/research/5gf9dn/eu_pharmaceutical?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/eu-pharmaceutical-regulations--strategy-seminar-london-united-kingdom---october-30th-31st-2018-300683893.html

SOURCE Research and Markets

View Comments and Join the Discussion!